Business Context and Reporting Period
This Form 8-K Current Report was filed by Healthcare Trust of America, Inc. (NYSE: HTA) and Healthcare Trust of America Holdings, LP on September 27, 2019. The filing addresses a regulatory disclosure under Item 7.01 regarding a revised Prospectus Supplement for an existing equity sale program.
Key Financial Metrics
The filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The only financial figure disclosed relates to the company's capital raising program:
- At-the-Market (ATM) Program: Originally announced as a $500.0 million program.
- Remaining Capacity: Approximately $447.3 million of Class A common stock remains unsold under the program.
- Recent Sales: No sales of Class A common stock were made under the ATM Program since the disclosures in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.
Material Changes
The filing discloses the submission of a Revised Prospectus Supplement. This action was necessitated solely by the filing of Post-Effective Amendment No. 1 to the company's registration statement on Form S-3ASR (File No. 333-223172) on September 5, 2019. The filing explicitly states that this revision does not otherwise change the terms or structure of the previously described ATM Program.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies beyond the procedural update to the equity offering documentation. The information provided in Item 7.01 is deemed "furnished" and not "filed" under the Securities Exchange Act of 1934, meaning it is not incorporated by reference into other registration statements unless expressly referenced.
Investor Verification Checklist
- Verify the status of the $447.3 million remaining capacity in the ATM Program in subsequent filings.
- Review the Post-Effective Amendment No. 1 to Form S-3ASR (File No. 333-223172) filed on September 5, 2019, to understand the specific regulatory changes necessitating the revised prospectus.
- Confirm that no equity sales occurred under the ATM Program between the June 30, 2019, 10-Q filing and this September 27, 2019, report.